Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 365

1.

Transthyretin Glu54Leu - an unknown mutation within the Swedish population associated with amyloid cardiomyopathy and a unique fibril type.

Hellman U, Lång K, Ihse E, Jonasson J, Olsson M, Lundgren HE, Pilebro B, Westermark P, Wixner J, Anan I.

Scand J Clin Lab Invest. 2019 Jun 6:1-5. doi: 10.1080/00365513.2019.1624977. [Epub ahead of print]

PMID:
31169435
2.

Cryo-EM fibril structures from systemic AA amyloidosis reveal the species complementarity of pathological amyloids.

Liberta F, Loerch S, Rennegarbe M, Schierhorn A, Westermark P, Westermark GT, Hazenberg BPC, Grigorieff N, Fändrich M, Schmidt M.

Nat Commun. 2019 Mar 7;10(1):1104. doi: 10.1038/s41467-019-09033-z.

3.

Amyloid fibril composition within hereditary Val30Met (p. Val50Met) transthyretin amyloidosis families.

Suhr OB, Wixner J, Anan I, Lundgren HE, Wijayatunga P, Westermark P, Ihse E.

PLoS One. 2019 Feb 27;14(2):e0211983. doi: 10.1371/journal.pone.0211983. eCollection 2019.

4.

Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee.

Benson MD, Buxbaum JN, Eisenberg DS, Merlini G, Saraiva MJM, Sekijima Y, Sipe JD, Westermark P.

Amyloid. 2018 Dec;25(4):215-219. doi: 10.1080/13506129.2018.1549825. Epub 2019 Jan 7.

PMID:
30614283
5.

Diurnal variation in egg excretion by Heterakis gallinarum.

Daş G, Westermark PO, Gauly M.

Parasitology. 2019 Feb;146(2):206-212. doi: 10.1017/S0031182018001075. Epub 2018 Jul 6.

PMID:
29978775
6.

Development of Mouse Monoclonal Antibodies Against Human Amyloid Fibril Proteins for Diagnostic and Research Purposes.

Westermark GT, Ihse E, Westermark P.

Methods Mol Biol. 2018;1779:401-414. doi: 10.1007/978-1-4939-7816-8_24.

PMID:
29886546
7.

Post mortem findings and their relation to AA amyloidosis in free-ranging Herring gulls (Larus argentatus).

Jansson DS, Bröjer C, Neimanis A, Mörner T, Murphy CL, Otman F, Westermark P.

PLoS One. 2018 Mar 1;13(3):e0193265. doi: 10.1371/journal.pone.0193265. eCollection 2018.

8.

Circadian clock-dependent and -independent posttranscriptional regulation underlies temporal mRNA accumulation in mouse liver.

Wang J, Symul L, Yeung J, Gobet C, Sobel J, Lück S, Westermark PO, Molina N, Naef F.

Proc Natl Acad Sci U S A. 2018 Feb 20;115(8):E1916-E1925. doi: 10.1073/pnas.1715225115. Epub 2018 Feb 5.

9.

Reduced left atrial myocardial deformation irrespective of cavity size: a potential cause for atrial arrhythmia in hereditary transthyretin amyloidosis.

Henein MY, Suhr OB, Arvidsson S, Pilebro B, Westermark P, Hörnsten R, Lindqvist P.

Amyloid. 2018 Mar;25(1):46-53. doi: 10.1080/13506129.2018.1430027. Epub 2018 Jan 25.

PMID:
29369708
10.

Guidelines for Genome-Scale Analysis of Biological Rhythms.

Hughes ME, Abruzzi KC, Allada R, Anafi R, Arpat AB, Asher G, Baldi P, de Bekker C, Bell-Pedersen D, Blau J, Brown S, Ceriani MF, Chen Z, Chiu JC, Cox J, Crowell AM, DeBruyne JP, Dijk DJ, DiTacchio L, Doyle FJ, Duffield GE, Dunlap JC, Eckel-Mahan K, Esser KA, FitzGerald GA, Forger DB, Francey LJ, Fu YH, Gachon F, Gatfield D, de Goede P, Golden SS, Green C, Harer J, Harmer S, Haspel J, Hastings MH, Herzel H, Herzog ED, Hoffmann C, Hong C, Hughey JJ, Hurley JM, de la Iglesia HO, Johnson C, Kay SA, Koike N, Kornacker K, Kramer A, Lamia K, Leise T, Lewis SA, Li J, Li X, Liu AC, Loros JJ, Martino TA, Menet JS, Merrow M, Millar AJ, Mockler T, Naef F, Nagoshi E, Nitabach MN, Olmedo M, Nusinow DA, Ptáček LJ, Rand D, Reddy AB, Robles MS, Roenneberg T, Rosbash M, Ruben MD, Rund SSC, Sancar A, Sassone-Corsi P, Sehgal A, Sherrill-Mix S, Skene DJ, Storch KF, Takahashi JS, Ueda HR, Wang H, Weitz C, Westermark PO, Wijnen H, Xu Y, Wu G, Yoo SH, Young M, Zhang EE, Zielinski T, Hogenesch JB.

J Biol Rhythms. 2017 Oct;32(5):380-393. doi: 10.1177/0748730417728663. Epub 2017 Nov 3.

11.

Origin of Cardiac Troponin T Elevations in Chronic Kidney Disease.

van der Linden N, Cornelis T, Kimenai DM, Klinkenberg LJJ, Hilderink JM, Lück S, Litjens EJR, Peeters FECM, Streng AS, Breidthardt T, van Loon LJC, Bekers O, Kooman JP, Westermark PO, Mueller C, Meex SJR.

Circulation. 2017 Sep 12;136(11):1073-1075. doi: 10.1161/CIRCULATIONAHA.117.029986. No abstract available.

PMID:
28893963
12.

Systemic AA amyloidosis in the red fox (Vulpes vulpes).

Rising A, Cederlund E, Palmberg C, Uhlhorn H, Gaunitz S, Nordling K, Ågren E, Ihse E, Westermark GT, Tjernberg L, Jörnvall H, Johansson J, Westermark P.

Protein Sci. 2017 Nov;26(11):2312-2318. doi: 10.1002/pro.3264. Epub 2017 Sep 13.

13.

Seed-dependent templating of murine AA amyloidosis.

Nyström S, Vahdat Shariat Panahi A, Nilsson KPR, Westermark P, Westermark GT, Hammarström P, Lundmark K.

Amyloid. 2017 Mar;24(sup1):140-141. doi: 10.1080/13506129.2017.1290599. No abstract available.

PMID:
28434369
14.

The challenging histological diagnosis of transthyretin (ATTR) amyloidosis.

Charkhkar E, Westermark P.

Amyloid. 2017 Mar;24(sup1):130-131. doi: 10.1080/13506129.2017.1296422. No abstract available.

PMID:
28434352
15.

Different population - different prevalence or, what is going on in the European brown hare (Lepus europaeus).

Posautz A, Kübber-Heiss A, Westermark P.

Amyloid. 2017 Mar;24(sup1):142-143. doi: 10.1080/13506129.2017.1290600. No abstract available.

PMID:
28434349
16.

Domino liver transplantation: full-length transthyretin in donor and recipient patients with ATTR Val30Met amyloidosis.

Westermark P, Nowak G, Suhr OB, Ericzon BG.

Amyloid. 2017 Mar;24(sup1):128-129. doi: 10.1080/13506129.2017.1294058. No abstract available.

PMID:
28434334
17.

Transthyretin amyloidosis: an under-recognized neuropathy and cardiomyopathy.

Galant NJ, Westermark P, Higaki JN, Chakrabartty A.

Clin Sci (Lond). 2017 Mar 1;131(5):395-409. doi: 10.1042/CS20160413. Review.

PMID:
28213611
18.

Principles for circadian orchestration of metabolic pathways.

Thurley K, Herbst C, Wesener F, Koller B, Wallach T, Maier B, Kramer A, Westermark PO.

Proc Natl Acad Sci U S A. 2017 Feb 14;114(7):1572-1577. doi: 10.1073/pnas.1613103114. Epub 2017 Feb 3.

19.

Noncerebral Amyloidoses: Aspects on Seeding, Cross-Seeding, and Transmission.

Westermark GT, Fändrich M, Lundmark K, Westermark P.

Cold Spring Harb Perspect Med. 2018 Jan 2;8(1). pii: a024323. doi: 10.1101/cshperspect.a024323. Review.

PMID:
28108533
20.

One mutation, two distinct disease variants: unravelling the impact of transthyretin amyloid fibril composition.

Suhr OB, Lundgren E, Westermark P.

J Intern Med. 2017 Apr;281(4):337-347. doi: 10.1111/joim.12585. Epub 2017 Jan 17. Review.

21.

Amyloid fibril proteins and amyloidosis: chemical identification and clinical classification International Society of Amyloidosis 2016 Nomenclature Guidelines.

Sipe JD, Benson MD, Buxbaum JN, Ikeda SI, Merlini G, Saraiva MJ, Westermark P.

Amyloid. 2016 Dec;23(4):209-213. Epub 2016 Nov 24.

PMID:
27884064
22.

Positron emission tomography (PET) utilizing Pittsburgh compound B (PIB) for detection of amyloid heart deposits in hereditary transthyretin amyloidosis (ATTR).

Pilebro B, Arvidsson S, Lindqvist P, Sundström T, Westermark P, Antoni G, Suhr O, Sörensen J.

J Nucl Cardiol. 2018 Feb;25(1):240-248. doi: 10.1007/s12350-016-0638-5. Epub 2016 Sep 19.

PMID:
27645889
23.

Linking Core Promoter Classes to Circadian Transcription.

Westermark PO.

PLoS Genet. 2016 Aug 9;12(8):e1006231. doi: 10.1371/journal.pgen.1006231. eCollection 2016 Aug.

24.

Corrigendum: Substoichiometric inhibition of transthyretin misfolding by immune-targeting sparsely populated misfolding intermediates: a potential diagnostic and therapeutic for TTR amyloidoses.

Galant NJ, Bugyei-Twum A, Rakhit R, Walsh P, Sharpe S, Arslan PE, Westermark P, Higaki JN, Torres R, Tapia J, Chakrabartty A.

Sci Rep. 2016 Jun 10;6:27679. doi: 10.1038/srep27679. No abstract available.

25.

Differential rhythmicity: detecting altered rhythmicity in biological data.

Thaben PF, Westermark PO.

Bioinformatics. 2016 Sep 15;32(18):2800-8. doi: 10.1093/bioinformatics/btw309. Epub 2016 May 20.

PMID:
27207944
26.

Electron tomography reveals the fibril structure and lipid interactions in amyloid deposits.

Kollmer M, Meinhardt K, Haupt C, Liberta F, Wulff M, Linder J, Handl L, Heinrich L, Loos C, Schmidt M, Syrovets T, Simmet T, Westermark P, Westermark GT, Horn U, Schmidt V, Walther P, Fändrich M.

Proc Natl Acad Sci U S A. 2016 May 17;113(20):5604-9. doi: 10.1073/pnas.1523496113. Epub 2016 May 2.

27.

Substoichiometric inhibition of transthyretin misfolding by immune-targeting sparsely populated misfolding intermediates: a potential diagnostic and therapeutic for TTR amyloidoses.

Galant NJ, Bugyei-Twum A, Rakhit R, Walsh P, Sharpe S, Arslan PE, Westermark P, Higaki JN, Torres R, Tapia J, Chakrabartty A.

Sci Rep. 2016 Apr 28;6:25080. doi: 10.1038/srep25080. Erratum in: Sci Rep. 2016 Jun 10;6:27679.

28.

(11)C and (18)F Radiolabeling of Tetra- and Pentathiophenes as PET-Ligands for Amyloid Protein Aggregates.

Nordeman P, Johansson LB, Bäck M, Estrada S, Hall H, Sjölander D, Westermark GT, Westermark P, Nilsson L, Hammarström P, Nilsson KP, Antoni G.

ACS Med Chem Lett. 2016 Feb 18;7(4):368-73. doi: 10.1021/acsmedchemlett.5b00309. eCollection 2016 Apr 14.

29.

Clinical and ultrastructural spectrum of diffuse lung disease associated with surfactant protein C mutations.

Peca D, Boldrini R, Johannson J, Shieh JT, Citti A, Petrini S, Salerno T, Cazzato S, Testa R, Messina F, Onofri A, Cenacchi G, Westermark P, Ullmann N, Cogo P, Cutrera R, Danhaive O.

Eur J Hum Genet. 2016 May;24(5):780. doi: 10.1038/ejhg.2016.12. No abstract available.

30.

Transmissible amyloid.

Tjernberg LO, Rising A, Johansson J, Jaudzems K, Westermark P.

J Intern Med. 2016 Aug;280(2):153-63. doi: 10.1111/joim.12499. Epub 2016 Mar 22. Review.

31.

Establishing the fluorescent amyloid ligand h-FTAA for studying human tissues with systemic and localized amyloid.

Sjölander D, Röcken C, Westermark P, Westermark GT, Nilsson KP, Hammarström P.

Amyloid. 2016 Jun;23(2):98-108. doi: 10.3109/13506129.2016.1158159. Epub 2016 Mar 17.

PMID:
26987044
32.

(99m)Tc-DPD uptake reflects amyloid fibril composition in hereditary transthyretin amyloidosis.

Pilebro B, Suhr OB, Näslund U, Westermark P, Lindqvist P, Sundström T.

Ups J Med Sci. 2016;121(1):17-24. doi: 10.3109/03009734.2015.1122687. Epub 2016 Feb 5.

33.

A novel transthyretin Lys70Glu (p.Lys90Glu) mutation presenting with vitreous amyloidosis and carpal tunnel syndrome.

Raivio VE, Jonasson J, Myllykangas L, Ala-Mello S, Kankuri-Tammilehto M, Kiuru-Enari S, Westermark P, Tanskanen M, Kivelä T.

Amyloid. 2016;23(1):46-50. doi: 10.3109/13506129.2015.1126574. Epub 2016 Feb 1.

PMID:
26828956
34.

Knee osteoarthritis associated with different kinds of amyloid deposits and the impact of aging on type of amyloid.

Yanagisawa A, Ueda M, Sueyoshi T, Nakamura E, Tasaki M, Suenaga G, Motokawa H, Toyoshima R, Kinoshita Y, Misumi Y, Yamashita T, Sakaguchi M, Westermark P, Mizuta H, Ando Y.

Amyloid. 2016;23(1):26-32. doi: 10.3109/13506129.2015.1115758. Epub 2015 Dec 24.

PMID:
26701417
35.

Amyloid Cardiomyopathy in Hereditary Transthyretin V30M Amyloidosis - Impact of Sex and Amyloid Fibril Composition.

Arvidsson S, Pilebro B, Westermark P, Lindqvist P, Suhr OB.

PLoS One. 2015 Nov 23;10(11):e0143456. doi: 10.1371/journal.pone.0143456. eCollection 2015.

36.

Changes among Associate Editors.

Westermark P.

Amyloid. 2015;22(4):209. doi: 10.3109/13506129.2015.1108301. Epub 2015 Nov 16. No abstract available.

PMID:
26575526
37.

Circadian mRNA expression: insights from modeling and transcriptomics.

Lück S, Westermark PO.

Cell Mol Life Sci. 2016 Feb;73(3):497-521. doi: 10.1007/s00018-015-2072-2. Epub 2015 Oct 26. Review.

PMID:
26496725
38.

Eighty years of research on islet amyloidosis in Uppsala.

Westermark GT, Oskarsson M, Andersson A, Westermark P.

Ups J Med Sci. 2015 May;120(2):117-23. doi: 10.3109/03009734.2015.1037032. Epub 2015 Apr 22. No abstract available.

39.

Lars Grimelius and his silver impregnation method--Commentaries on the paper in Upsala Journal of Medical Sciences with the highest number of citations.

Westermark P.

Ups J Med Sci. 2015 May;120(2):113-6. doi: 10.3109/03009734.2015.1023910. Epub 2015 Mar 17. No abstract available.

40.

Clinical and ultrastructural spectrum of diffuse lung disease associated with surfactant protein C mutations.

Peca D, Boldrini R, Johannson J, Shieh JT, Citti A, Petrini S, Salerno T, Cazzato S, Testa R, Messina F, Onofri A, Cenacchi G, Westermark P, Ullmann N, Cogo P, Cutrera R, Danhaive O.

Eur J Hum Genet. 2015 Aug;23(8):1033-41. doi: 10.1038/ejhg.2015.45. Epub 2015 Mar 18. Erratum in: Eur J Hum Genet. 2016 May;24(5):780. Ullman, Nicola [corrected to Ullmann, Nicola].

41.

A genealogical and clinical study of the phenotypical variation within the Swedish transthyretin His88Arg (p. His108Arg) amyloidosis family.

Hellman U, Lundgren HE, Westermark P, Stafberg C, Nahi H, Tachlinski S, Guggi M, Flogegård M, Hamid M, Escher SA, Suhr OB.

Eur J Med Genet. 2015 Apr;58(4):211-5. doi: 10.1016/j.ejmg.2015.02.005. Epub 2015 Feb 24.

PMID:
25721874
42.

In vivo seeding and cross-seeding of localized amyloidosis: a molecular link between type 2 diabetes and Alzheimer disease.

Oskarsson ME, Paulsson JF, Schultz SW, Ingelsson M, Westermark P, Westermark GT.

Am J Pathol. 2015 Mar;185(3):834-46. doi: 10.1016/j.ajpath.2014.11.016. Epub 2015 Feb 17.

PMID:
25700985
43.

AA amyloidosis: pathogenesis and targeted therapy.

Westermark GT, Fändrich M, Westermark P.

Annu Rev Pathol. 2015;10:321-44. doi: 10.1146/annurev-pathol-020712-163913. Epub 2014 Oct 29. Review.

PMID:
25387054
44.

Rhythmic degradation explains and unifies circadian transcriptome and proteome data.

Lück S, Thurley K, Thaben PF, Westermark PO.

Cell Rep. 2014 Oct 23;9(2):741-51. doi: 10.1016/j.celrep.2014.09.021. Epub 2014 Oct 16.

45.

Detecting rhythms in time series with RAIN.

Thaben PF, Westermark PO.

J Biol Rhythms. 2014 Dec;29(6):391-400. doi: 10.1177/0748730414553029. Epub 2014 Oct 17.

46.

Nomenclature 2014: Amyloid fibril proteins and clinical classification of the amyloidosis.

Sipe JD, Benson MD, Buxbaum JN, Ikeda S, Merlini G, Saraiva MJ, Westermark P.

Amyloid. 2014 Dec;21(4):221-4. doi: 10.3109/13506129.2014.964858. Epub 2014 Sep 29. No abstract available.

47.

Amyloid deposits derived from transthyretin in the ligamentum flavum as related to lumbar spinal canal stenosis.

Yanagisawa A, Ueda M, Sueyoshi T, Okada T, Fujimoto T, Ogi Y, Kitagawa K, Tasaki M, Misumi Y, Oshima T, Jono H, Obayashi K, Hirakawa K, Uchida H, Westermark P, Ando Y, Mizuta H.

Mod Pathol. 2015 Feb;28(2):201-7. doi: 10.1038/modpathol.2014.102. Epub 2014 Sep 5.

48.

Carbonic anhydrase generates CO2 and H+ that drive spider silk formation via opposite effects on the terminal domains.

Andersson M, Chen G, Otikovs M, Landreh M, Nordling K, Kronqvist N, Westermark P, Jörnvall H, Knight S, Ridderstråle Y, Holm L, Meng Q, Jaudzems K, Chesler M, Johansson J, Rising A.

PLoS Biol. 2014 Aug 5;12(8):e1001921. doi: 10.1371/journal.pbio.1001921. eCollection 2014 Aug.

49.

Online registry for mutations in hereditary amyloidosis including nomenclature recommendations.

Rowczenio DM, Noor I, Gillmore JD, Lachmann HJ, Whelan C, Hawkins PN, Obici L, Westermark P, Grateau G, Wechalekar AD.

Hum Mutat. 2014 Sep;35(9):E2403-12. doi: 10.1002/humu.22619. Epub 2014 Aug 4.

PMID:
25044787
50.

Transthyretin-derived amyloidosis: probably a common cause of lumbar spinal stenosis.

Westermark P, Westermark GT, Suhr OB, Berg S.

Ups J Med Sci. 2014 Aug;119(3):223-8. doi: 10.3109/03009734.2014.895786. Epub 2014 Mar 12.

Supplemental Content

Loading ...
Support Center